MALWOOD

This brand name is authorized in Nigeria.

Active ingredients

The drug MALWOOD contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII C7D6T3H22J - ARTEMETHER
 

Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
 
Read more about Artemether
2
UNII F38R0JR742 - LUMEFANTRINE
 
Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100830 Tablet MALWOOD TABLETS TAB 80 mg; 480 mg 1 X 6 67 NF-PP-384480 MALWOOD TABLETS ARTEMETHER 80MG + LUMEFANTRINE 480MG Artemether 80 mg Lumefantrine480 mg, PVPK-30 BP ? Isopropyl Alcohol BP ? Microcrystalline Cellulose BP ? Croscarmellose Sodium BP ? Sodium Starch Glycolate BP ? Maize Starch BP ? Sodium Lauryl Sulfate BP ? Purified Talc BP ? Colloidal Anhydrous Silica BP ? Magnesium Stearate BP A4-100830 Drugs ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS Imported Products 1X6 POM 2 11/14/2023 HALEWOOD LABORATORIES PVT LTD, JOHNSON STREET,OFF COKER ILUPEJU LAGOS 9122879817 africa@halewoodlabs.com HALEWOOD LABORATORIES PVT.LTD, PLOT NO.319, PHASE-II, G.I.D.C., VATVA, AHMEDABAD-382 445, GUJARAT, INDIA., India 30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BF01 Artemether and lumefantrine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100830

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈